SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2111guffaw.... didn't see it, and couldn't have seen it. But it does looscaram(o)uche-10/1/2008
2110So how many hundred million did you pick up ?nigel bates-10/1/2008
2109beat this one for firesale, percent-speaking...... Message 25014862scaram(o)uche-10/1/2008
2108VRNM is down 50% on 8X aver vol. Around 52 w low.(Former Diversa and purchased Cpoodle-9/30/2008
2107Gentium (GENT) off 20% on highish volume and no news. Again, it would seem sometuck-9/26/2008
2106<i>OPXA on Friday -90% on P2b news </i> Opexa shares lose most of vatnsaf-9/22/2008
2105SRDX closed down 21% on the news released late Wednesday that MRK had canceled SDewDiligence_on_SI-9/18/2008
2104SOMX down about 20% yesterday on no news that I can find. JackJack@SI-9/18/2008
2103ArQule (ARQL) off 15% to multi-year lows on somewhat high volume and no news. Ytuck-9/18/2008
2102SRDX off 18% in AH trading on news of MRK’s dumping ophthalmic collaboration: sDewDiligence_on_SI-9/17/2008
2101trgt off 40% ah. <i>AstraZeneca and Targacept Announce Top-Line Results fkeokalani'nui-9/15/2008
2100Good points. Great question. I was wondering the same thing.rkrw-9/9/2008
2099Synvista Therapeutics (SYI) (nee Alteon) off 16% on no news, very light volume.tuck-9/9/2008
2098Good point, certainly as it pertains to the Hanging Question from Dazed Analystskeokalani'nui-9/9/2008
2097The analysts on today’s BIOD CC missed an opportunity to fully unmask the companDewDiligence_on_SI-9/9/2008
2096I respectfully disagree. I think they are in trouble! True the T2D study was nokeokalani'nui19/8/2008
2095I don't know how closely you follow Biodel. My first read of the PR suggesttuck-9/8/2008
2094Biodel getting crunched, -60%.rkrw-9/8/2008
2093And more altu fallout. FORM 8-K CURRENT REPORT ---------------------------rkrw-9/8/2008
2092>>The reverse merger ascribes no value to NOVC’s pipeline because NOVC no tuck-9/3/2008
2091The reverse merger ascribes no value to NOVC’s pipeline because NOVC no longer &DewDiligence_on_SI-9/2/2008
2090Pressure Biosciences (PBIO), which seems to be a trickle play, is off 15% on ligtuck-9/2/2008
2089Introgen (INGN) off 41% to penny stock status, as the FDA unsurprisingly refusestuck19/2/2008
2088Novacea (NOVC) off 40% on an all stock take out by a private company. >>Utuck-9/2/2008
2087BFRM off 24% on no news: #msg-24891013. Perhaps they are buying THRM after all.DewDiligence_on_SI-8/29/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News